Nick Marchand is a manager within Pall’s Research & Development group focused on bioprocess testing of new equipment and consumables. He has previous experience in process development groups at Genzyme and Amgen. He holds a B.S. and Ph.D. from Rensselaer Polytechnic Institute.

Talks

• Placing filtration into gene therapy platforms – potential and remaining challenges